Literature DB >> 20955911

Urologic complications of the neurogenic bladder.

E Ann Gormley1.   

Abstract

Patients with a neurogenic bladder are at risk for several urologic complications including hydronephrosis, vesicoureteral reflux, renal failure, urinary tract infections, calculus disease, bladder cancer, sexual dysfunction including infertility, and the destroyed bladder and urethra. The management of filling bladder pressures and regular, complete emptying, ideally with clean intermittent catheterization, can prevent or delay many of these complications. Even with optimum management, complications may still develop over time, necessitating regular urologic follow-up to recognize, treat, and prevent further complications. The ultimate goal of the urologist in treating the patient with a neurogenic bladder is to allow for preservation of renal function and continence with minimum complications.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20955911     DOI: 10.1016/j.ucl.2010.07.002

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  25 in total

1.  Ultrasound findings of the urinary tract in patients with spinal cord injury: a study of 1005 cases.

Authors:  Ü Güzelküçük; Y Demir; S Kesikburun; B Aras; E Yaşar; A K Tan
Journal:  Spinal Cord       Date:  2014-11-04       Impact factor: 2.772

2.  Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1.

Authors:  Rosana C P Andrade; José A Neto; Luciana Andrade; Tatiane S Oliveira; Dislene N Santos; Cassius J V Oliveira; Márcio J Prado; Edgar M Carvalho
Journal:  Urology       Date:  2015-12-24       Impact factor: 2.649

3.  [Neuro-urological diagnosis and therapy of lower urinary tract dysfunction in patients with spinal cord injury : S2k Guideline of the German-Speaking Medical Society of Paraplegia (DMGP), AWMF register no. 179/001].

Authors:  R Böthig; B Domurath; A Kaufmann; J Bremer; W Vance; I Kurze
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

4.  Urinary tract infections in patients with spinal cord injuries.

Authors:  Frederiek D'Hondt; Karel Everaert
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

Review 5.  Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury.

Authors:  Mikolaj Przydacz; Piotr Chlosta; Jacques Corcos
Journal:  Int Urol Nephrol       Date:  2018-03-22       Impact factor: 2.370

6.  Flexible ureteroscopic laser lithotripsy for upper urinary tract stone disease in patients with spinal cord injury.

Authors:  Abdulkadir Tepeler; Brian C Sninsky; Stephen Y Nakada
Journal:  Urolithiasis       Date:  2015-05-19       Impact factor: 3.436

7.  Remodeling of extracellular matrix in the urinary bladder of paraplegic rats results in increased compliance and delayed fiber recruitment 16 weeks after spinal cord injury.

Authors:  Tyler G Tuttle; Heidi L Lujan; Nathan R Tykocki; Stephen E DiCarlo; Sara Roccabianca
Journal:  Acta Biomater       Date:  2022-01-13       Impact factor: 8.947

8.  Change in urodynamic pattern and incidence of urinary tract infection in patients with traumatic spinal cord injury practicing clean self-intermittent catheterization.

Authors:  Osama Neyaz; Venkataraman Srikumar; Ameed Equebal; Abhishek Biswas
Journal:  J Spinal Cord Med       Date:  2018-10-02       Impact factor: 1.985

9.  Urolithiasis and the risk of ESRD.

Authors:  Ziad M El-Zoghby; John C Lieske; Robert N Foley; Eric J Bergstralh; Xujian Li; L Joseph Melton; Amy E Krambeck; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

10.  Detrusor underactivity: Pathophysiological considerations, models and proposals for future research. ICI-RS 2013.

Authors:  Gommert A van Koeveringe; Kevin L J Rademakers; Lori A Birder; Cees Korstanje; Firouz Daneshgari; Michael R Ruggieri; Yasuhiko Igawa; Christopher Fry; Adrian Wagg
Journal:  Neurourol Urodyn       Date:  2014-05-16       Impact factor: 2.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.